Honz Pharmaceutical Co.Ltd(300086) : Haitong Securities Company Limited(600837) special verification opinions on the storage and use of Honz Pharmaceutical Co.Ltd(300086) raised funds in 2021

Haitong Securities Company Limited(600837)

About Honz Pharmaceutical Co.Ltd(300086)

Special verification opinions on the deposit and use of raised funds in 2021

Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor”) as a sponsor of Honz Pharmaceutical Co.Ltd(300086) (hereinafter referred to as ” Honz Pharmaceutical Co.Ltd(300086) ” or “the company”) issued shares for the first time in 2010 and listed on the gem, in accordance with the law on the administration of securities issuance and listing sponsor business and the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of funds raised by listed companies According to the requirements of relevant laws and regulations and normative documents, such as self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 13 – recommendation business, self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM, the deposit and use of raised funds in 3 Ning Xia Yin Xing Energy Co.Ltd(000862) 021 have been carefully verified. The details are as follows:

1、 Basic information of raised funds

(I) actual time of funds raised

With the approval of zjxk [2010] No. 549 document of China Securities Regulatory Commission, Honz Pharmaceutical Co.Ltd(300086) on May 13, 2010, publicly issued 25 million RMB ordinary shares to the public, with a par value of RMB 1 per share and an issue price of RMB 60. The total amount of funds raised was RMB 15000000000. After deducting the underwriting Commission, issuance handling fee, lawyer’s fee and other issuance expenses of securities companies, the total amount was RMB 5120230000, The net amount of funds actually raised is RMB 144879770000. The above funds were fully paid on May 18, 2010 and verified by the capital verification report “zsiyyz [2010] No. 01020003” issued by ZHONGSHEN International Certified Public Accountants Co., Ltd.

(II) amount used in previous years, amount used in current year and current balance

Time and amount (yuan)

As of December 31, 2020, the balance of raised funds was 7144624737 plus: interest income of the current year was 422205971 minus: amount used in the current year was 286466062; as of December 31, 2021, the balance of raised funds was 7280364646

2、 Management of raised funds

(I) formulation and implementation of raised funds management system

The company has complied with the requirements of laws and regulations such as the measures for the administration of securities issuance by listed companies, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for the self-discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, etc, The management system of raised funds has been formulated, and the company adopts a special account storage system for raised funds.

(II) signing of special account for raised funds

The company signed the tripartite supervision agreement on raised funds with Haitong Securities Company Limited(600837) and Haikou Branch of Shenzhen Development Bank Co., Ltd. (later renamed Ping An Bank Co.Ltd(000001) Haikou Branch), Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch and Haikou Rural Commercial Bank Co., Ltd. on May 28, 2010, June 1, 2010 and October 15, 2012 respectively.

On December 31, 2015, the company transferred the special fund-raising account from Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch to Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, cancelled the special fund-raising account of Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch, and signed a tripartite supervision agreement on fund-raising with Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch.

On November 27, 2013, the company signed the four party supervision agreement on raised funds with the wholly-owned subsidiary Hainan Kangzhi Biotechnology Co., Ltd. (formerly Hainan Kangzhi Pharmaceutical Marketing Co., Ltd., renamed on September 30, 2019, hereinafter referred to as “Kangzhi biotechnology”), Haitong Securities Company Limited(600837) and Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch; On December 31, 2013, the supplementary agreement to the four party supervision agreement on raised funds was signed.

On December 31, 2015, the company signed the four party supervision agreement on raised funds with Kangzhi biology, Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, transferring the special account for raised funds from Industrial And Commercial Bank Of China Limited(601398) to Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch, and canceling the special account for raised funds of Industrial And Commercial Bank Of China Limited(601398) Haikou Xiuying sub branch.

On March 30, 2015, the company signed the four party supervision agreement on raised funds with its wholly-owned subsidiaries Guangdong Kangda Pharmaceutical Co., Ltd. (hereinafter referred to as “Kangda pharmaceutical”), Haitong Securities Company Limited(600837) and Liede Avenue sub branch of Guangzhou Branch of Guangdong Development Bank Co., Ltd.

On July 20, 2018, the company, Kangda pharmaceutical, Haitong Securities Company Limited(600837) and Guangzhou Branch Liede Avenue sub branch of Guangdong Development Bank Co., Ltd. signed the four party supervision agreement on raised funds (special account for super raised funds of hand, foot and mouth disease project).

On November 21, 2012, the company signed the four party supervision agreement on raising funds with the holding subsidiaries Beijing Shunxin Xiangyun Pharmaceutical Co., Ltd. (hereinafter referred to as “Xiangyun pharmaceutical”), Haitong Securities Company Limited(600837) and Bank Of China Limited(601988) Beijing Shunyi Auto City sub branch.

On December 31, 2015, the company signed the four party supervision agreement on raised funds with Xiangyun pharmaceutical, Haitong Securities Company Limited(600837) and Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch, transferred the special account for raised funds from Bank Of China Limited(601988) Beijing Shunyi Auto City sub branch to Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch, and transferred all the remaining raised funds to the new raised funds account within the current month, and cancelled the original raised funds account.

On July 10, 2017, the wholly-owned subsidiary Zhongshan Hongshi Health Technology Co., Ltd. (hereinafter referred to as “Zhongshan Hongshi”), Haitong Securities Company Limited(600837) and Liede Avenue sub branch of Guangzhou Branch of Guangdong Development Bank Co., Ltd. signed the tripartite supervision agreement on the storage of special account for raised funds.

The contents of the above three-party or four-party regulatory agreements are drafted with reference to the model of Shenzhen Stock Exchange, and there is no significant difference. (III) storage of raised funds in special account

As of December 31, 2021, the balance of the special account for the deposit of raised funds is as follows:

Company name deposit bank account balance (yuan) remarks

Ping An Bank Co.Ltd(000001) Haikou Haidian sub branch 11004088765607189145484 current account

110040887656020.00 periodic

Honz Pharmaceutical Co.Ltd(300086) share demand

Ltd. Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch 4616023030188 Norinco International Cooperation Ltd(000065) 14370751813

4616023030180100843509122.44 current account

Haikou rural commercial bank business department 10070987 China Vanke Co.Ltd(000002) 3811663.88 current account

Hainan Kangzhi biology 4616023030188 Tunghsu Azure Renewable Energy Co.Ltd(000040) 6273.65 current

Technology Co., Ltd. Bank Of Communications Co.Ltd(601328) Haikou Nanhai sub branch current account

4616023030188 North Huajin Chemical Industries Co.Ltd(000059) 55 25,570556.06

Guangdong Kangda pharmaceutical Guangdong Development Bank Guangzhou Branch Liede Avenue sub branch 12130151101 Shenzhen Wongtee International Enterprise Co.Ltd(000056) 378395853 current account

Ltd. Guangzhou Branch Liede Avenue sub branch of Guangdong Development Bank 9550880052310043454266178 current account

Beijing Shunxin Xiangyun 11006116201801020051223907971 current account

Pharmaceutical Co., Ltd. Bank Of Communications Co.Ltd(601328) Beijing Shunyi sub branch

Company 11006116201801 New Hua Du Supercenter Co.Ltd(002264) 5204.84 current account

Zhongshan Hongshi health Guangfa Bank Guangzhou Branch Liede Avenue sub branch current account

Technology Co., Ltd. 9550880267330 Goody Science & Technology Co.Ltd(002694) 7152.60

Total 7280364646

(IV) cash management of raised funds

On December 11, 2020, the 11th meeting of the 5th board of directors deliberated and approved the proposal on using idle raised funds for cash management, and agreed that the company (including its holding subsidiaries and subsidiaries) could use the temporarily idle raised funds (including over raised funds) with a maximum amount of no more than 75 million yuan for cash management in a timely manner on the premise that the raised investment projects are carried out normally and the active investment and M & a work is not affected, For the purchase of investment products of commercial banks with high security, good liquidity, principal guaranteed commitment and a term of no more than 12 months, the funds can be used on a rolling basis within the above limit, and the management is authorized to handle it in detail.

The details of the company and its subsidiaries using the raised funds for cash management in 2021 are shown in the following table:

Unit: 10000 yuan

Whether the related party is responsible for financial remuneration and whether the actual amount in the current period is subject to the trustee’s name relationship, the transaction product type, the starting date and ending date, and the specified principal amount has been recovered in a certain way

Bank of communications Haikou Nanhai no demand structured deposit s 32 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency branch

Bank of communications Haikou Nanhai no demand structured deposit s 23 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency sub branch

Bank of communications Haikou Nanhai no demand structured deposit s fund 11 Zoje Resources Investment Co.Ltd(002021) / 1 / 1 2021 / 9 / 23 currency branch

Total 6600

As of December 31, 2021, the balance of the company’s use of raised funds to purchase bank investment and financial products is zero. 3、 Actual use of raised funds

As of December 31, 2021, the company has used 16286901 million yuan of raised funds, including 2815768 million yuan of investment projects with raised funds and 134 million yuan of investment projects with over raised funds

- Advertisment -